Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anemia, Kidney Disease, Chronic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01052779
What this trial is testing

A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease

Who this might be right for
Iron DeficiencyAnemiaKidney Disease
AMAG Pharmaceuticals, Inc. 162
Post-approval studies (Phase 4)Study completedNCT00239642
What this trial is testing

Safety and Efficacy of Iron Sucrose in Children

Who this might be right for
AnemiaChronic Kidney Disease
American Regent, Inc. 141
Large-scale testing (Phase 3)Ended earlyNCT00462384
What this trial is testing

Subcutaneous Mircera for the Treatment of Anemia in Pre-Dialysis Participants With Chronic Kidney Disease.

Who this might be right for
Anemia
Hoffmann-La Roche 39
Large-scale testing (Phase 3)Study completedNCT04707768
What this trial is testing

Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis Subjects

Who this might be right for
Anemia Associated With Chronic Kidney Disease (CKD)
Akebia Therapeutics 456
Large-scale testing (Phase 3)Not Yet RecruitingNCT07296146
What this trial is testing

Probiotics Against Erythropoietin Resistance in Chronic Kidney Disease Patients.

Who this might be right for
AnaemiaChronic Kidney DiseaseRegular Hemodialysis
Badr University 80
Large-scale testing (Phase 3)Ended earlyNCT00422513
What this trial is testing

A Study Comparing Mircera and Epoetin Alfa for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.

Who this might be right for
Anemia
Hoffmann-La Roche 260
Testing effectiveness (Phase 2)Ended earlyNCT02378662
What this trial is testing

TARGTEPO Treatment for Anemia in End Stage Renal Disease (ESRD) Patients Undergoing Peritoneal Dialysis (PD)

Who this might be right for
Anemia of End Stage Renal Disease
Aevi Genomic Medicine, LLC, a Cerecor company 2
Post-approval studies (Phase 4)Study completedNCT00298441
What this trial is testing

Efficacy of Intravenous Iron Administration in Hemodialysis Patients

Who this might be right for
Chronic Renal FailureHemodialysisRenal Anemia+1 more
Kumamoto University 50
Large-scale testing (Phase 3)Study completedNCT00317239
What this trial is testing

VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease

Who this might be right for
Anemia
American Regent, Inc. 255
Not applicableStudy completedNCT05240677
What this trial is testing

Endoscopy in CKD With Iron Deficiency Anemia

Who this might be right for
Chronic Kidney DiseasesIron-Deficiency Anemia
Walid Ahmed Ragab Abdelhamid 81
Not applicableStudy completedNCT01054066
What this trial is testing

Managing Chronic Kidney Disease in Eastern North Carolina

Who this might be right for
Chronic Kidney Disease
East Carolina University 1,257
Large-scale testing (Phase 3)Study completedNCT05085275
What this trial is testing

Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

Who this might be right for
Anemia, Iron DeficiencyHyperphosphatemiaRenal Insufficiency, Chronic+4 more
USRC Kidney Research 289
Post-approval studies (Phase 4)WithdrawnNCT01151592
What this trial is testing

Safety Assessment of Iron Sucrose (Venofer) in Patients With Chronic Kidney Disease Who Cannot Tolerate Ferumoxytol (Feraheme) or Iron Dextran (INFed or Dexferrum)

Who this might be right for
Iron Deficiency Anemia
American Regent, Inc.
Testing effectiveness (Phase 2)Study completedNCT03731741
What this trial is testing

Does Oral Pentoxifylline Administration Improve Hemoglobin in Hemodialysis Patients?

Who this might be right for
Anemia of Chronic Kidney Disease
Tanta University 57
Large-scale testing (Phase 3)Study completedNCT02912494
What this trial is testing

A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)

Who this might be right for
Anemia
Kissei Pharmaceutical Co., Ltd.
Post-approval studies (Phase 4)Ended earlyNCT01737879
What this trial is testing

Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Patients Receiving Hemodialysis

Who this might be right for
Anemia
Amgen 41
Not applicableNot Yet RecruitingNCT07755683
What this trial is testing

Effect of Daprodustat and Epoetin Alpha on Anemia in Patients Not Undergoing Dialysis

Who this might be right for
Chronic Kidney Disease (Stages 3b-5)Anemia Associated With Chronic Kidney Disease
Services Hospital, Lahore 60
Not applicableUnknownNCT03005847
What this trial is testing

The Effect of Fermented Papaya Preparation on Patients With Chronic Kidney Disease Under Dialysis Receiving Intravenous Iron

Who this might be right for
AnemiaChronic Kidney Disease Stage 5
Hadassah Medical Organization 20
Not applicableStudy completedNCT02540213
What this trial is testing

Observational Study of MIRCERA in Users of Self-Application and Multidose Systems

Who this might be right for
Renal Anemia of Chronic Kidney Disease
Hoffmann-La Roche 240
Testing effectiveness (Phase 2)Study completedNCT03054350
What this trial is testing

Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Dialysis-Dependent Chronic Kidney Disease (DD-CKD)

Who this might be right for
AnemiaDialysis Dependent Chronic Kidney Disease
Akebia Therapeutics 60
Next Page